Janette Glaser, Ph.D.

spinal cord injury

Hans Keirstead	grad student	2006	UC Irvine
(The role of CXCL10 following spinal cord injury and the benefits of anti -CXCL10 treatment.)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Menaker J, Kufera JA, Glaser J, et al. (2013) Admission ASIA motor score predicting the need for tracheostomy after cervical spinal cord injury. The Journal of Trauma and Acute Care Surgery. 75: 629-34
Glaser J, Gonzalez R, Sadr E, et al. (2006) Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. Journal of Neuroscience Research. 84: 724-34
Gonzalez R, Hardison JL, Glaser J, et al. (2006) The chemokine CXCL10 as a therapeutic target in animal models of neuroinflammatory disease Letters in Drug Design and Discovery. 3: 683-688
Glaser J, Gonzalez R, Perreau VM, et al. (2004) Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. Journal of Neuroscience Research. 77: 701-8
Gonzalez R, Glaser J, Liu MT, et al. (2003) Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Experimental Neurology. 184: 456-63